As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.
15 Analysts have issued a Monte Rosa Therapeutics Inc forecast:
15 Analysts have issued a Monte Rosa Therapeutics Inc forecast:
Jun '25 |
+/-
%
|
||
Revenue | 178 178 |
2,990%
2,990%
|
|
Gross Profit | - - |
-
|
|
EBITDA | 23 23 |
118%
118%
|
EBIT (Operating Income) EBIT | 15 15 |
111%
111%
|
Net Profit | 24 24 |
119%
119%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Monte Rosa Therapeutics, Inc. operates as a biotechnology company focused on developing precision medicines. The company was founded on November 21, 2019 and is headquartered in Boston, MA.
Head office | United States |
CEO | Markus Warmuth |
Employees | 142 |
Founded | 2019 |
Website | www.monterosatx.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.